Friday 10-07-2020 Post #15 FarmaKology

Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to “[email protected]”, and happy to have you featured on our newsletter (+6266 Subscribers )!

Issue #50 Issue #51

News

Gilead says additional data on remdesivir shows improved clinical recovery

Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery in severely ill COVID-19 patients. Findings from an analysis of its late-stage study showed that 74.4% of remdesivir-treated patients recovered by Day 14 versus 59.0% of patients receiving standard of care, the company said.

CVS Pharmacy introduces new app feature for reading “talking” prescription labels

CVS Pharmacy announced that it has developed Spoken Rx, a new feature of the CVS Pharmacy app that can read a specific type of label for patients with visual impairments and those who cannot read standard print labels. Spoken Rx is the first in-app prescription reader application to be developed by a national retail pharmacy. By the end of 2020, 1,500 CVS Pharmacy locations will be equipped to affix special RFID labels to prescription vials. When the RFID labels are scanned by Spoken Rx in the CVS Pharmacy app, which can be accessed by users using Siri or Google Assistant on their phones, prescription label information will be spoken out loud.

ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics

ProteinQure, a leader in computational protein drug discovery, announces a collaboration with the global biopharmaceutical company AstraZeneca to apply structure-based design to the creation of therapeutic libraries with the aim of accelerating the research and development of peptide therapeutics. Peptide therapeutics have unique properties that make them highly effective against some disease targets outside the scope of traditional small molecule and antibody modalities. However, due to the number of peptide variations, very few of these potential therapeutics have been studied. Integrating high-accuracy biophysical models and machine learning, it is possible to explore this vast therapeutic space and design peptide libraries with broad applicability in drug discovery.

Kymera Therapeutics And Sanofi Enter Into Strategic Partnership To Advance Novel Protein Degrader Therapies To Patients

 Kymera Therapeutics Inc. today announced the company has entered into a multi-program strategic collaboration with Sanofi to develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases. The companies will also partner on a second earlier stage program. Kymera will receive $150 million in cash upfront and may receive more than $2 billion in potential development, regulatory and sales milestones, as well as significant royalty payments. Kymera retains the option to participate in US development and commercialization for both programs. This includes the ability to participate equally in the costs, profits and losses after opt-in, and to co-promote partnered products in the US.

Merck Opens its Largest M Lab? Collaboration Center in Shanghai

Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centres worldwide.“With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase in R&D on leading-edge treatments including cell and gene therapies in China,” said Udit Batra, member of the Merck Executive Board and CEO, Life Science. “Our M LabTM Collaboration Center offers customizable solutions and services that help biopharmaceutical and biologics companies improve their processes from drug discovery, development to manufacturing — saving costs and increasing speed to market.”With a total lab size of approximately 10,000m2, Merck’s newest M LabTM Collaboration Center is located in Pudong, at the heart of the biomedical sciences and research community in Shanghai.

Research & Study

Medical care for very ill COVID-19 patients is getting better

Scientists discover protective Alzheimer's gene and develop the rapid drug-testing platform

Researchers set up Gate2Brain to exploit a novel drug-transporting technology

Podcast

Job Opportunities

Medical Representative

Pharmacy Technician

clinical pharmacist

Pharmacist

Upcoming Webinar

Virtual Reality in Medicine and Clinical Research

A.G.P.'s Grand Rounds feat. OncoSec

Video